诉讼概述 - Bernstein Liebhard LLP律师事务所宣布，已代表在2025年2月26日至2025年8月4日期间（含首尾两日）购买或收购agilon health, inc.证券的投资者提起集体诉讼 [1] 指控内容 - 根据诉讼，被告方在公司的2025年业绩指引等方面做出了虚假陈述 [2] 诉讼程序信息 - 希望作为首席原告的股东必须在2026年3月2日前提交文件 [3] - 首席原告是代表其他集体成员指导诉讼的代表方 [3] - 股东无需担任首席原告也能分享任何可能的赔偿 [3] - 所有代理均基于风险代理收费，股东无需支付费用或开支 [3] 律师事务所背景 - Bernstein Liebhard LLP自1993年以来已为客户追回超过35亿美元 [4] - 该律所除代表个人投资者外，还受雇于美国一些最大的公共和私人养老基金，以监控其资产并代表其提起诉讼 [4] - 因其在数百起集体诉讼中的成功，该律所十三次被《国家法律杂志》列入“原告热门名单”，并连续十六年被列入《法律500强》 [4]

SAN DIEGO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired agilon health, inc. (NYSE: AGL) securities between February 26, 2025 and August 4, 2025. agilon describes itself as the "trusted partner empowering physicians to transform health care in our communities."For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.The Allegations: Robbins LLP is ...

集体诉讼事件概述 - 律师事务所Robbins LLP提醒投资者 针对agilon health inc (NYSE AGL) 的集体诉讼已提交 诉讼代表在2025年2月26日至2025年8月4日期间购买或获得公司证券的所有投资者 [1] 指控内容 - 指控公司就其业务前景误导投资者 具体包括公司鲁莽地发布了其知道或应该知道无法实现的2025年业绩指引 尽管公司知晓行业存在重大不利因素 [2] - 指控公司严重夸大了其为降低风险所采取的“战略行动”能带来的即时积极财务影响 [2] 事件触发与市场反应 - 2025年8月4日 公司宣布总裁 首席执行官兼董事会董事Steven Sell已离职 提交给美国证券交易委员会的8-K表格显示 Sell先生的离职属于雇佣协议下的“无因”解雇 [3] - 同一天 公司发布了令人失望的财务业绩 此消息导致公司股价下跌超过50% 于2025年8月5日收盘报0.8801美元 [3] 公司业务描述 - agilon health inc 自称为“值得信赖的合作伙伴 致力于赋能医生改变我们社区的医疗保健” [1]

NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York on behalf of all persons or entities who purchased or otherwise acquired Agilon Health, Inc. (“Agilon” or the “Company”) (NYSE: AGL) securities between February 26, 2025, and August 4, 2025. The Complaint alleges that (i) Defendants recklessly issued guidance for 2025 that they knew or should have known ...

核心诉讼事件 - 针对agilon health公司已提起联邦证券集体诉讼 代表在2025年2月6日至2025年8月4日期间购入公司股票的投资者[1] - 诉讼指控公司及其部分高管和/或董事从事证券欺诈或其他非法商业行为[2] - 投资者申请成为首席原告的截止日期为2026年3月2日[1][3] 触发事件与市场反应 - 2025年8月4日 公司发布了两份新闻稿 内容涉及领导层变动和财务更新[3][7] - 公司总裁、首席执行官兼董事会董事Steven Sell已卸任[7] - 公司公布了2025年第二季度业绩 并指出行业阻力“比此前预期的更为严峻”[7] - 公司暂停了其2025年全年的财务指引[7] - 公告发布后 公司股价在2025年8月5日下跌每股0.94美元 跌幅达51.52% 收盘报0.88美元[3]

NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against agilon health, inc. (“Agilon” or the “Company”) (NYSE: AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. The class action concerns whether Agilon and certain of its offic ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In agilon health To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in agilon health between February 26, 2025 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YORK, Jan. 6, 2026 /PRNewswire/ -- Fa ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Agilon (AGL) To Contact Him Directly To Discuss Their Options If you purchased or acquired Agilon securities between February 26, 2025 and August 4, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Forunato directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- What’s Happening: Braga ...

SAN DIEGO, Jan. 5, 2026 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired agilon health, inc. (NYSE: AGL) securities between February 26, 2025 and August 4, 2025. Agilon describes itself as the "trusted partner empowering physicians to transform health care in our communities." For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is I ...

NEW YORK--(BUSINESS WIRE)---- $AGL #AGL--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against agilon health, inc. ("agilon†or the "Company†) (NYSE: AGL) and reminds investors of the March 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has. ...